Use of a computerised decision support system in pharmacies can prevent overuse of high-dose proton pump inhibitor (PPIs), Australian research shows.
The authors of the study, from the University of Tasmania school of pharmacy, said the findings showed that decision support software in community pharmacy improved quality use of medicines.
In the study, 73 community pharmacies randomised to use electronic prompts activated while dispensing high-dose PPIs (40 mg esomeprazole or 40 mg pantroprazole) had a rate of 1.67 pharmacist-recorded PPI interventions per 100 PPI prescriptions compared with 0.17 in 112 pharmacy-controls after 12 weeks.
During the first 28 days of the trial, 196 interventions resulted in 34 instances of PPI step-down, with the majority of these occurring in pharmacies using the PPI electronic...
This site is intended for Registered Medical Practitioners.
To make the most of Pharmacy News, you need to be logged in.